Travere Therapeutics, Inc. TVTX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s current ratio?
- Travere Therapeutics, Inc. (TVTX) reported current ratio of 3.1× in Q1 2026.
- How has Travere Therapeutics, Inc.'s current ratio changed year-over-year?
- Travere Therapeutics, Inc.'s current ratio increased by 52.7% year-over-year, from 2.1× to 3.1×.
- What is the long-term trend for Travere Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s current ratio has grown at a -9.2% compound annual growth rate (CAGR), from 4.4× to 2.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.